Oral bisphosphonates and incidence of cancers in patients with osteoporosis: a systematic review and meta-analysis

Purpose Several previous studies have shown that oral bisphosphonates (BPs) are associated with the incidence of 13 specific cancers, including lung cancer, esophageal cancer, gastric cancer, and colorectal cancer (CRC). However, the findings are heterogeneous.